Department of Gynecology, Juning No.1 People's Hospital, Jining, Shandong 272100, China.
J BUON. 2021 Jan-Feb;26(1):288.
Retraction of: 'Swerchirin exerts anticancer activity on SKOV3 human ovarian cancer cells via induction of mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of Raf/MEK/ERK cascade', by Lan Luo, Haibo Zhao, Qian Luo, JBUON 2018;23(1):111-116; PMID:29552769. Following the publication of the above article, readers drew to our attention that part of the data was unreliable. The authors were requested to provide the raw data to prove the originality, but were unable to do so. After an investigation, the Editors of JBUON decided to retract this article. We thank the readers for bringing this matter to our attention. We apologize for any inconvenience it may cause.
“Swerchirin 通过诱导线粒体凋亡、G2/M 细胞周期阻滞和抑制 Raf/MEK/ERK 级联反应对 SKOV3 人卵巢癌细胞发挥抗癌活性”,作者:Lan Luo、Haibo Zhao、Qian Luo,发表于 JBUON 2018 年;23(1):111-116;PMID:29552769。在发表上述文章后,读者提请我们注意部分数据不可靠。要求作者提供原始数据以证明其原创性,但他们无法提供。经过调查,JBUON 的编辑决定撤回这篇文章。我们感谢读者对此事的关注。我们对由此造成的任何不便表示歉意。